{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:46:27Z","timestamp":1761745587427,"version":"3.41.2"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Myasthenia gravis (MG) is an autoimmune, neuromuscular condition and patients with MG are vulnerable due to immunosuppressant use and disease manifestations of dyspnea and dysphagia during the coronavirus disease 2019 (COVID-19) pandemic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective cohort study using the Optum<jats:sup>\u00ae<\/jats:sup> de-identified COVID-19 Electronic Health Record (EHR) dataset. Primary outcomes, such as hospitalization, ventilator use, intensive care unit (ICU) admission, and death in COVID-19 patients with MG, were compared with those of COVID-19 patients without MG: the subgroups of non-MG included those with rheumatoid arthritis (RA), systemic lupus (SLE), and multiple sclerosis (MS). We further analyzed factors affecting mortality, such as age, race\/ethnicity, comorbidities, and MG treatments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 421,086 individuals with COVID-19, there were 377 patients with MG, 7,362 patients with RA, 1,323 patients with SLE, 1,518 patients with MS, and 410,506 patients without MG. Patients with MG were older and had more comorbidities compared with non-MG patients and had the highest rates of hospitalization (38.5%), ICU admission (12.7%), ventilator use (3.7%), and mortality (10.6%) compared with all other groups. After adjusting for risk factors, patients with MG had increased risks for hospitalization and ICU compared with patients with non-MG and with RA but had risks similar to patients with SLE and with MS. The adjusted risk for ventilator use was similar across all groups, but the risk for mortality in patients with MG was lower compared with the SLE and MS groups. Among patients with MG, age over 75 years and dysphagia were predictors for increased COVID-19 mortality, but the recent MG treatment was not associated with COVID-19 mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>COVID-19 patients with MG are more likely to be admitted to the hospital and require ICU care. Older age and patients with dysphagia had an increased risk of mortality.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.802559","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:20:18Z","timestamp":1648603218000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["COVID-19 Outcomes in Myasthenia Gravis Patients: Analysis From Electronic Health Records in the United States"],"prefix":"10.3389","volume":"13","author":[{"given":"Youngran","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minseon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziz","family":"Shaibani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazim","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thy Phuong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1756286420932036","DOI":"10.1177\/1756286420932036","article-title":"Neurological manifestations and implications of COVID-19 pandemic","volume":"13","author":"Tsivgoulis","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"key":"B2","doi-asserted-by":"publisher","first-page":"102174","DOI":"10.1016\/j.msard.2020.102174","article-title":"The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic","volume":"43","author":"Baker","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"B3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","article-title":"Neurological associations of COVID-19","volume":"19","author":"Ellul","year":"2020","journal-title":"Lancet Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology","volume":"36","author":"Hehir","year":"2018","journal-title":"Neurol Clin"},{"key":"B5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1212\/WNL.0000000000009566","article-title":"COVID-19 and neuromuscular disorders","volume":"94","author":"Guidon","year":"2020","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"116803","DOI":"10.1016\/j.jns.2020.116803","article-title":"Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic","volume":"412","author":"International MG\/COVID-19 Working","year":"2020","journal-title":"J Neurol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s13760-021-01612-6","article-title":"Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay","volume":"121","author":"Galassi","year":"2021","journal-title":"Acta Neurol Belg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"102468","DOI":"10.1016\/j.jaut.2020.102468","article-title":"The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19","volume":"111","author":"Perricone","year":"2020","journal-title":"J Autoimmun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3332\/ecancer.2020.1022","article-title":"Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence","volume":"14","author":"Russell","year":"2020","journal-title":"Ecancermedicalscience"},{"key":"B10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S1474-4422(20)30413-0","article-title":"COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)","volume":"19","author":"Muppidi","year":"2020","journal-title":"Lancet Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"117362","DOI":"10.1016\/j.jns.2021.117362","article-title":"Electronic health record derived-impact of COVID-19 on myasthenia gravis","volume":"423","author":"Roy","year":"2021","journal-title":"J Neurol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.neurol.2020.04.004","article-title":"Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network","volume":"176","author":"Sol\u00e9","year":"2020","journal-title":"Rev Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/mus.26918","article-title":"COVID-19 in patients with myasthenia gravis","volume":"62","author":"Anand","year":"2020","journal-title":"Muscle Nerve"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3389\/fneur.2020.01053","article-title":"Myasthenia gravis and COVID-19: clinical characteristics and outcomes","volume":"11","author":"Camelo-Filho","year":"2020","journal-title":"Front Neurol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"117053","DOI":"10.1016\/j.jns.2020.117053","article-title":"Description of 3 patients with myasthenia gravis and COVID-19","volume":"417","author":"Rein","year":"2020","journal-title":"J Neurol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3233\/JND-200520","article-title":"COVID-19 in Refractory Myasthenia Gravis- A case report of successful outcome","volume":"7","author":"Ramaswamy","year":"2020","journal-title":"J Neuromuscul Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1136\/jnnp-2020-323565","article-title":"Management of patients with generalised myasthenia gravis and COVID-19: four case reports","volume":"91","author":"H\u00fcbers","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"106045","DOI":"10.1016\/j.clineuro.2020.106045","article-title":"COVID-19 and generalized Myasthenia Gravis exacerbation: a case report","volume":"196","author":"Singh","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"576153","DOI":"10.3389\/fneur.2020.576153","article-title":"Postinfectious onset of Myasthenia Gravis in a COVID-19 patient","volume":"11","author":"Huber","year":"2020","journal-title":"Front Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1007\/s00415-020-10263-1","article-title":"New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review","volume":"268","author":"Sriwastava","year":"2021","journal-title":"J Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.7326\/L20-0845","article-title":"Myasthenia Gravis associated with SARS-CoV-2 infection","volume":"173","author":"Restivo","year":"2020","journal-title":"Ann Intern Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"116888","DOI":"10.1016\/j.jns.2020.116888","article-title":"Myasthenic crisis in COVID-19","volume":"414","author":"Delly","year":"2020","journal-title":"J Neurol Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1212\/WNL.0b013e3181a41211","article-title":"Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals","volume":"72","author":"Alshekhlee","year":"2009","journal-title":"Neurology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"103744","DOI":"10.1016\/j.jbi.2021.103744","article-title":"ELII: a novel inverted index for fast temporal query, with application to a large Covid-19 EHR dataset","volume":"117","author":"Huang","year":"2021","journal-title":"J Biomed Inform"},{"key":"B26","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1111\/ene.14951","article-title":"Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival","volume":"28","author":"Jakub\u00edkov\u00e1","year":"2021","journal-title":"Eur J Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s13760-019-01102-w","article-title":"A study of comorbidities in myasthenia gravis","volume":"120","author":"Misra","year":"2020","journal-title":"Acta Neurol Belg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"10001","DOI":"10.7189\/jogh.11.10001","article-title":"Risk factors for poor outcomes in hospitalised COVID-19 patients: a systematic review and meta-analysis","volume":"11","author":"Li","year":"2021","journal-title":"J Glob Health"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e32487","DOI":"10.1371\/journal.pone.0032487","article-title":"Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity","volume":"7","author":"Sardu","year":"2012","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/00207454.2010.539307","article-title":"Frequency of autoimmune diseases in myasthenia gravis: a systematic review","volume":"121","author":"Mao","year":"2011","journal-title":"Int J Neurosci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/ene.12599","article-title":"Myasthenia gravis and risks for comorbidity","volume":"22","author":"Gilhus","year":"2015","journal-title":"Eur J Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1007\/s00415-011-6335-z","article-title":"The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature","volume":"259","author":"Jallouli","year":"2012","journal-title":"J Neurol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.msard.2019.06.027","article-title":"Co-occurrence of multiple sclerosis and myasthenia gravis: a case report and review of immunological theories","volume":"34","author":"Dehbashi","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"B35","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1136\/jnnp-2019-322606","article-title":"Rituximab in AChR subtype of myasthenia gravis: systematic review","volume":"91","author":"di Stefano","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00415-020-10064-6","article-title":"Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantine","volume":"268","author":"di Stefano","year":"2021","journal-title":"J Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.802559\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:20:20Z","timestamp":1648603220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.802559\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":36,"alternative-id":["10.3389\/fneur.2022.802559"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.802559","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"article-number":"802559"}}